Dupilumab in Atopic Dermatitis

被引:0
作者
Milagros Lázaro-Sastre
Asunción García-Sánchez
Aída Gómez-Cardeñosa
Ignacio Dávila
机构
[1] University Hospital,Department of Biomedical and Diagnostic Sciences, Faculty of Medicine
[2] University of Salamanca,undefined
[3] IBSAL,undefined
[4] Institute of Biomedical Research of Salamanca,undefined
[5] Fundación Jiménez Díaz,undefined
来源
Current Treatment Options in Allergy | 2019年 / 6卷
关键词
Atopic dermatitis; Dupilumab; Biologics; IL-4R; Clinical trials;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:211 / 225
页数:14
相关论文
共 347 条
[1]  
Weidinger S(2016)Atopic dermatitis Lancet Lond Engl 387 1109-1122
[2]  
Novak N(2017)Atopic dermatitis in adults: a diagnostic challenge J Investig Allergol Clin Immunol 27 78-88
[3]  
Silvestre Salvador JF(2015)Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities Allergy. 70 836-845
[4]  
Romero-Pérez D(2011)Atopic dermatitis in older patients: particular points J Eur Acad Dermatol Venereol JEADV 25 12-18
[5]  
Encabo-Durán B(2014)Atopic dermatitis and the atopic march revisited Allergy. 69 17-27
[6]  
Mortz CG(2008)The socioeconomic impact of atopic dermatitis in the United States: a systematic review Pediatr Dermatol 25 1-6
[7]  
Andersen KE(2017)Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey J Am Acad Dermatol 77 274-279.e3
[8]  
Dellgren C(2015)Off-label prescriptions for atopic dermatitis in Europe Allergy. 70 6-11
[9]  
Barington T(2011)Atopic dermatitis: a disease of altered skin barrier and immune dysregulation Immunol Rev 242 233-246
[10]  
Bindslev-Jensen C(2017)The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies J Allergy Clin Immunol 139 S65-S76